Annual Working Capital
$108.30 M
-$72.31 M-40.04%
31 December 2023
Summary:
Syros Pharmaceuticals annual working capital is currently $108.30 million, with the most recent change of -$72.31 million (-40.04%) on 31 December 2023. During the last 3 years, it has fallen by -$41.63 million (-27.77%). SYRS annual working capital is now -40.04% below its all-time high of $180.61 million, reached on 31 December 2022.SYRS Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$35.54 M
-$24.86 M-41.16%
30 September 2024
Summary:
Syros Pharmaceuticals quarterly working capital is currently $35.54 million, with the most recent change of -$24.86 million (-41.16%) on 30 September 2024. Over the past year, it has dropped by -$58.58 million (-62.24%). SYRS quarterly working capital is now -83.38% below its all-time high of $213.88 million, reached on 30 September 2022.SYRS Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SYRS Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -40.0% | -62.2% |
| 3 y3 years | -27.8% | -71.2% |
| 5 y5 years | +31.7% | -59.8% |
SYRS Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -40.0% | +3.1% | -83.4% | at low |
| 5 y | 5 years | -40.0% | +31.7% | -83.4% | at low |
| alltime | all time | -40.0% | +280.1% | -83.4% | +24.7% |
Syros Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $35.54 M(-41.2%) |
| June 2024 | - | $60.40 M(-19.4%) |
| Mar 2024 | - | $74.90 M(-30.8%) |
| Dec 2023 | $108.30 M(-40.0%) | $108.30 M(+15.1%) |
| Sept 2023 | - | $94.12 M(-24.3%) |
| June 2023 | - | $124.25 M(-17.2%) |
| Mar 2023 | - | $150.09 M(-16.9%) |
| Dec 2022 | $180.61 M(+71.9%) | $180.61 M(-15.6%) |
| Sept 2022 | - | $213.88 M(+303.4%) |
| June 2022 | - | $53.02 M(-40.4%) |
| Mar 2022 | - | $88.88 M(-15.4%) |
| Dec 2021 | $105.08 M(-29.9%) | $105.08 M(-14.8%) |
| Sept 2021 | - | $123.39 M(-22.2%) |
| June 2021 | - | $158.58 M(-20.4%) |
| Mar 2021 | - | $199.31 M(+32.9%) |
| Dec 2020 | $149.93 M | $149.93 M(+112.7%) |
| Sept 2020 | - | $70.50 M(-21.0%) |
| June 2020 | - | $89.25 M(-15.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $105.89 M(+16.4%) |
| Dec 2019 | $91.00 M(+10.7%) | $91.00 M(+2.9%) |
| Sept 2019 | - | $88.45 M(-18.9%) |
| June 2019 | - | $109.04 M(+73.7%) |
| Mar 2019 | - | $62.78 M(-23.6%) |
| Dec 2018 | $82.20 M(+35.3%) | $82.20 M(-12.8%) |
| Sept 2018 | - | $94.25 M(-13.8%) |
| June 2018 | - | $109.27 M(+7.1%) |
| Mar 2018 | - | $102.03 M(+68.0%) |
| Dec 2017 | $60.75 M(-20.0%) | $60.75 M(-17.8%) |
| Sept 2017 | - | $73.93 M(-14.2%) |
| June 2017 | - | $86.17 M(+31.3%) |
| Mar 2017 | - | $65.64 M(-13.6%) |
| Dec 2016 | $75.94 M(+166.5%) | $75.94 M(-12.2%) |
| Sept 2016 | - | $86.53 M(+88.1%) |
| June 2016 | - | $46.00 M(-20.4%) |
| Mar 2016 | - | $57.82 M(+102.9%) |
| Dec 2015 | $28.49 M(-51.9%) | $28.49 M |
| Dec 2014 | $59.29 M | - |
FAQ
- What is Syros Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Syros Pharmaceuticals?
- What is Syros Pharmaceuticals annual working capital year-on-year change?
- What is Syros Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Syros Pharmaceuticals?
- What is Syros Pharmaceuticals quarterly working capital year-on-year change?
What is Syros Pharmaceuticals annual working capital?
The current annual working capital of SYRS is $108.30 M
What is the all time high annual working capital for Syros Pharmaceuticals?
Syros Pharmaceuticals all-time high annual working capital is $180.61 M
What is Syros Pharmaceuticals annual working capital year-on-year change?
Over the past year, SYRS annual working capital has changed by -$72.31 M (-40.04%)
What is Syros Pharmaceuticals quarterly working capital?
The current quarterly working capital of SYRS is $35.54 M
What is the all time high quarterly working capital for Syros Pharmaceuticals?
Syros Pharmaceuticals all-time high quarterly working capital is $213.88 M
What is Syros Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, SYRS quarterly working capital has changed by -$58.58 M (-62.24%)